Condition
Placenta Accrete Spectrum
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Enrolling By Invitation1
Unknown1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07412925Not ApplicableRecruiting
Impact Tourniquet Conservative Placenta Accreta Neonatal APGAR
NCT07250412Not ApplicableEnrolling By InvitationPrimary
The Accuracy Of 3D Color Ultrasonography for Detecting the Degree of Placenta Accreta Spectrum Invasion
NCT04583540UnknownPrimary
Quality of Life in Postpartum Women With Placenta Accrete Spectrum.
Showing all 3 trials